Inamoto, Teruo

Anti-CD26 monoclonal antibody-mediated G1-S arrest of human renal clear cell carcinoma Caki-2 is associated with retinoblastoma substrate dephosphorylation, cyclin-dependent kinase 2 reduction, p27(kip1) enhancement, and disruption of binding to the extracellular matrix. [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research Jun 2006 - 3470-7 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1078-0432

10.1158/1078-0432.CCR-06-0361 doi


Animals
Antibodies, Monoclonal--immunology
Antigen-Antibody Reactions
Binding Sites
Carcinoma, Renal Cell--drug therapy
Cell Cycle--drug effects
Cell Line, Tumor
Cell Proliferation--drug effects
Cyclin-Dependent Kinase 2--metabolism
Cyclin-Dependent Kinase Inhibitor p27--biosynthesis
Dipeptidyl Peptidase 4--biosynthesis
Dipeptidyl-Peptidase IV Inhibitors
Disease Models, Animal
Dose-Response Relationship, Drug
Drug Screening Assays, Antitumor
Extracellular Matrix--drug effects
Female
G1 Phase--drug effects
Humans
Kidney Neoplasms--drug therapy
Mice
Mice, Inbred BALB C
Mice, Nude
Phosphorylation--drug effects
Retinoblastoma Protein--metabolism
S Phase--drug effects
Structure-Activity Relationship
Transplantation, Heterologous
Xenograft Model Antitumor Assays